Evidence map›Paper›PMID 41480745›Full record

ArticleJCI insight2026

SRSF3-TRIM28-MDC1 prevents DNA damage caused by R-loops in fatty liver disease in mice.

Panyisha Wu, Manasi Das, Yanting Wang, Yichun Ji, Yuli Wu, Deepak Kumar, Lily J Jih, Nicholas Jg Webster

Abstract read
In one paragraph

Article in JCI insight, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Panyisha WuA San Diego Healthcare System, San Diego, California, USA.
Manasi DasA San Diego Healthcare System, San Diego, California, USA.
Yanting WangDepartment of Medicine, Division of Endocrinology and Metabolism, University of California San Diego, La Jolla, California, USA.
Yichun JiDepartment of Medicine, Division of Endocrinology and Metabolism, University of California San Diego, La Jolla, California, USA.
Yuli WuDepartment of Medicine, Division of Endocrinology and Metabolism, University of California San Diego, La Jolla, California, USA.
Deepak KumarA San Diego Healthcare System, San Diego, California, USA.
Lily J JihA San Diego Healthcare System, San Diego, California, USA.
Nicholas Jg WebsterA San Diego Healthcare System, San Diego, California, USA.

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DIANE M SIMEONE · 1985 to 2026
$124.9M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MILES Frome WILKINSON · 2003 to 2026
$40.4M
San Diego Digestive Diseases Research CenterP30DK120515 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Bernd G. Schnabl · 2019 to 2026
$10.8M
U of Calif, San Diego Neuroscience Microscopy ImagingP30NS047101 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G, ZHENG, BINHAI · 2003 to 2022
$9.0M
Time-Restricted Feeding and Breast CancerR01CA196853 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NICHOLAS J WEBSTER · 2016 to 2026
$3.3M
Human Liver Tissue & Hepatocytes Research Resource (HLTHRR)R24DK139775 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DAVID A GELLER, Satdarshan Singh Monga · 2024 to 2026
$1.4M
The Effect of Time-Restricted Eating on the Efficiency of Chemo- and Hormonal-Therapy in Breast CancerR21CA288777 · NCI · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI WEBSTER, NICHOLAS J · 2024 to 2025
$369k
BLRD VA I01 BX002709BLRD VA I01 BX004848BLRD VA IK6 BX005224NCI NIH HHS P30 CA023100NCI NIH HHS R01 CA196853NCI NIH HHS R21 CA288777NIDDK NIH HHS P30 DK063491NIDDK NIH HHS P30 DK120515NIDDK NIH HHS R24 DK139775NINDS NIH HHS P30 NS047101
6 · The paper itself

Abstract

Serine-rich splicing factor 3 (SRSF3) is crucial for the metabolic functions of the liver. The genetic deletion of SRSF3 in mouse hepatocytes impairs hepatic lipid and glucose metabolism and leads to fibrosis and formation of hepatocellular adenoma that progresses to hepatocellular carcinoma. SRSF3 protein is proteosomally degraded in metabolic-dysfunction associated fatty liver disease (MAFLD) and metabolic-dysfunction-associated steatohepatitis (MASH). We show here that depleting SRSF3 protein in hepatocytes promoted R-loop accumulation and increased DNA damage in the liver. Prevention of SRSF3 degradation in vivo protected hepatocytes from DNA double-strand breaks in mice with MASH. This protection extended to other DNA-damaging agents such as camptothecin, palmitic acid, or hydrogen peroxide when tested on HepG2 cells in vitro. SRSF3 interacted with TRIM28 and MDC1, which are components of the ATM DNA-damage repair complex, and knockdown of any of these 3 proteins reduced the expression of the other 2 proteins, suggesting they form a functional complex. Lastly, by preventing degradation of SRSF3, we were able to reduce tumors in a diethyl-nitrosamine-induced (DEN-induced) model of cirrhotic HCC. These findings suggest that maintenance of SRSF3 protein stability is crucial for preventing DNA damage and protecting liver from early metabolic liver disease and progression to HCC.

Indexed as

DNA DamageFatty LiverSerine-Arginine Splicing FactorsAdaptor Proteins, Signal TransducingAnimalsCarcinoma, HepatocellularCell Cycle ProteinsDisease Models, AnimalHepatocytesHep G2 CellsHumansLiverLiver NeoplasmsMaleMiceMice, Inbred C57BLAdaptor Proteins, Signal TransducingCell Cycle ProteinsSerine-Arginine Splicing FactorsSrsf3 protein, mouseDNA repairEndocrinologyHepatologyLiver cancerRNA processing

Identifiers

PMID41480745
PMCPMC12890501

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.